Analysts have raised their price target for Rainbow Children's Medicare from ₹1,585.45 to ₹1,604.55, citing slight improvements in projected revenue growth and future earnings multiples.
What's in the News
- Mr. Abrarali Dalal has been appointed as the new Chief Executive Officer of Rainbow Children's Medicare, effective January 20, 2026. Dalal brings over 25 years of leadership experience in healthcare and related sectors, with a strong record in operational excellence and strategic transformation. (Board Announcement)
- The Board of Directors approved Dalal's appointment following recommendations from the Nomination and Remuneration Committee at a meeting held on November 13, 2025. (Board Announcement)
- At the same meeting, the Board reviewed and approved the unaudited financial results for the quarter and half year ended September 30, 2025. (Board Meeting)
Valuation Changes
- Consensus Analyst Price Target has risen slightly from ₹1,585.45 to ₹1,604.55.
- Discount Rate remains unchanged at 12.76%.
- Revenue Growth projection increased marginally from 17.71% to 17.87%.
- Net Profit Margin edged down slightly from 18.56% to 18.55%.
- Future P/E multiple increased modestly from 48.27x to 48.85x.
Have other thoughts on Rainbow Children's Medicare?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.